Rapport Therapeutics Statistics
NASDAQ: RAPPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
30.86-0.29 (-0.93%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Rapport Therapeutics by the numbers
Rapport Therapeutics has a market capitalization of $1.48 billion based on 47.98M shares outstanding. With trailing EPS of $-3.03, Rapport Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.4% below its 50-day average and 13.8% below its 200-day average.
Average daily trading volume is 370.01K shares, or about $11.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RAPP valuation vs. peer median
| Metric | RAPP | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.48B | $1.52B | -3% |
| Avg. volume | 370.01K | 712.77K | -48% |
Peer median across 8 companies: SNDX, RARE, INVA, PAHC, GHRS, KRSA, STOK, ETON.
Valuation
- Market cap
- $1.48B
- EPS (TTM)
- $-3.03
- Shares outstanding
- 47.98M
Price and trading
- Previous close
- 31.15
- Open
- 30.81
- Day range
- 30.46 – 31.35
- 52-week range
- 23.75 – 52.93
- 52-week change
- +16.72%
- Beta
- —
- Volume
- 314.91K
- Average volume
- 370.01K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.48B
- Forward Pe
- -5.90
- Eps
- -3.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 52.93
- Week52 Low
- 23.75
- Avg Volume
- 370.01K
- Shares Outstanding
- 47.98M
- Ma50
- 43.11
- Ma200
- 35.81
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -41.70%
- Pct From52w Low
- 29.94%